[Congressional Record Volume 172, Number 70 (Tuesday, April 21, 2026)]
[House]
[Pages H3003-H3004]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
FUNDING FOR RESEARCH UNDER THREAT
(Mr. Magaziner of Rhode Island was recognized to address the House
for 5 minutes.)
Mr. MAGAZINER. Mr. Speaker, a recent vaccine trial for patients with
pancreatic cancer using mRNA technology produced an astounding result:
Pancreatic cancer is one of the deadliest forms of cancer.
More than 90 percent of people diagnosed with pancreatic cancer die
within 2 years, but among those who were in this vaccine trial, half
are still alive today, more than 6 years later.
If these results continue in future rounds of the trial, we will have
made an incredible breakthrough that could give new hope not only to
those with pancreatic cancer but other forms of cancer, as well. This
is just one of many ongoing studies showing great promise.
Unfortunately, right when we are on the cusp of making incredible
advances in the fight against cancer, the funding for this research is
under threat.
Last year, the White House proposed cutting funding for cancer
research by 40 percent and canceled a number of research grants. Some
of the biggest cuts have been to research of mRNA, the same technology
used in the successful pancreatic cancer trial.
In August, the administration canceled grants for 22 mRNA vaccine
research studies alone. This does not make America healthier.
My own family has been afflicted by cancer. I know the agony people
feel when they receive that terrible diagnosis, the horrible process of
chemo and radiation, the cost, and the sorrow that American families
have had to live with because of a serious cancer diagnosis.
We cannot turn our backs on those families when we are so close to
finding
[[Page H3004]]
real cures. We have to continue funding the research.
The truth is that, even before the current administration, we weren't
doing enough. Last year, the Federal Government spent about $7 billion
on cancer research. The war in Iran is costing us more than a billion
dollars a day.
Think about that. We will spend more on the war in Iran in 1 week
than we spend on cancer research in an entire year. Think about the
lives that could be saved and the families who would get to spend more
holidays and graduations with their loved ones if we had the right
priorities.
We don't need to spend billions more on unnecessary wars in the
Middle East or ballrooms or more ICE agents. Instead, let's do what we
do best as a country and invest in innovation and science to save
lives.
{time} 1045
Stock-Trading Ban
Mr. MAGAZINER. Mr. Speaker, it has been exactly 1 year since Speaker
Johnson said that he supports a stock-trading ban for Members of
Congress. One year, and what has happened? Absolutely nothing.
We need to pass a congressional stock-trading ban because it is not
fair that Members of Congress have access to inside information that
influences major industries--the pharmaceutical industry, the tech
industry, and others--and can trade off of that information that
average Americans don't have.
By the way, Members of Congress should not be conflicted when making
decisions about how to legislate. The overwhelming majority of the
American people want this reform. They understand that we have a
corruption problem in Washington.
If a bill were brought to the floor today, it would pass
overwhelmingly. I have a bipartisan bill along with Chip Roy, and
Members on both the left, right, and center: Pramila Jayapal,
Alexandria Ocasio-Cortez, Brian Fitzpatrick, and Tim Burchett. We have
a great bill with over 100 cosponsors. We could vote on that today, and
it would pass.
We have got a discharge petition. We can get this done. We need a
Speaker with the courage to do the right thing and call a vote.
____________________